Diabetic neuropathies

Diabetologia

Volumn 40, Issue SUPPL. 3, 1997, Pages

  Sima, A A F ^a,e   Thomas, P K ^b   Ishii, D ^c   Vinik, A ^d  

^a WAYNE STATE UNIVERSITY   (United States)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c Department of Ecosystem Science and Sustainability   (United States)

^d EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^e Gordon H Scott Hall Basic Med Sci ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; INSULIN; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NEUROTROPIC AGENT; SCAVENGER; SOMATOMEDIN;

CLINICAL FEATURE; CONFERENCE PAPER; DEMYELINATING NEUROPATHY; DIABETIC NEUROPATHY; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MOTOR NEUROPATHY; NERVE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN BIOPSY;

ANIMALS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; HUMANS;

EID: 0030763487     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051409     Document Type: Conference Paper

References (11)

1. American Diabetes Association, American Academy of Neurology (1988) Consensus statement: report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes Care 11: 592-597
2. Clinical Practice Recommendations (1995) American Diabetes Association: Standardized measures in diabetic neuropathy. Diabetes Care [Suppl 1] 18: 59-82
3. Migdalis TN, Kalogeropoulou K, Kalantzis L, Nounopoulos C, Bouloukos A, Samartzis M (1995) Insulin-like growth factor-I and IGF-I receptors in diabetic patients with neuropathy. Diabet Med 12: 823-827
4. Ishii DN (1995) Implications of insulin-like growth factors in the pathogenesis of diabetic neuropathy. Brain Res Reviews 20: 47-67
5. Zhuang H-X, Snyder CK, Pu S-F, Ishii DN (1996) Insulin-like growth factors reverse or arrest diabetic neuropathy in rats: effects on hyperalgesia and impaired nerve regeneration. Exp Neurol 140: 198-205
6. Apfel S, Adornato B, Dyek PJ et al. and the Nerve Growth Factor Group (1996) Results of a double-blind, placebo-controlled trial of a recombinant human nerve growth factor in diabetic polyneuropathy. Ann Neurol 40: 954
7. Sima AAF, Nathaniel V, Bril V, McEwen TAJ, Greene DA (1988) Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy. J Clin Invest 81: 349-364
8. Sima AAF, Merry AC, Grant M, Murray FT, Guberski D (1997) The BB/ZDR-rat: A model for type II diabetic neuropathy. LADVII, Copenhagen (abstract)
9. Yagihashi S (1995) Pathology and pathogenetic mechanisms of diabetic neuropathy. In: Sima AAF, Ward JD (eds) Nervous system abnormalities in diabetes. Diabetes Metab Rev 11: 193-226
10. Krendel DA, Costigan DA, Hopkins LC (1995) Successful treatment of neuropathies in patients with diabetes mellitus. Arch Neurol 52: 1053-1061
11. Ross MA, Taylor TR, Vinik A (1993) Strategies for easing pain. Patient Care 27(20):48-72